PortfoliosLab logoPortfoliosLab logo
ASND vs. VALE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASND vs. VALE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and Vale S.A. (VALE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASND achieves a 18.20% return, which is significantly higher than VALE's 12.43% return. Over the past 10 years, ASND has outperformed VALE with an annualized return of 33.14%, while VALE has yielded a comparatively lower 17.54% annualized return.


ASND

1D
-0.94%
1M
-4.42%
6M
13.31%
YTD
18.20%
1Y
54.33%
3Y*
39.37%
5Y*
16.35%
10Y*
33.14%
ALL TIME*
23.87%

VALE

1D
-0.34%
1M
-2.53%
6M
-12.59%
YTD
12.43%
1Y
55.90%
3Y*
9.37%
5Y*
1.86%
10Y*
17.54%
ALL TIME*
13.64%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$121.90M$138.27M$171.88M
$278.54M$302.28M$354.07M

ASND vs. VALE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ASND
Ascendis Pharma A/S
18.20%54.89%9.31%3.13%-9.22%-19.34%19.88%122.06%56.39%97.92%
VALE
Vale S.A.
12.43%60.70%-38.83%1.57%32.54%-1.45%32.40%2.72%12.25%68.03%

Correlation

The correlation between ASND and VALE is 0.14, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.14

Correlation (3Y)
Balances recent behavior with more history.

0.12

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.14

Correlation (10Y)
Provides a long-term view across more market conditions.

0.14

Correlation (All Time)
Calculated using the full available price history since Jan 28, 2015

0.12

Fundamentals

Market Cap

ASND:

$15.66B

VALE:

$62.48B

EPS

ASND:

€8.13

VALE:

$0.65

PE Ratio

ASND:

27.05

VALE:

22.42

PS Ratio

ASND:

15.79

VALE:

1.58

PB Ratio

ASND:

29.05

VALE:

1.71

Total Revenue (TTM)

ASND:

€867.51M

VALE:

$39.53B

Gross Profit (TTM)

ASND:

€764.89M

VALE:

$13.65B

EBITDA (TTM)

ASND:

-€6.94M

VALE:

$14.33B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASND vs. VALE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND
ASND Risk / Return Rank: 8585
Overall Rank
ASND Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
ASND Sortino Ratio Rank: 8383
Sortino Ratio Rank
ASND Omega Ratio Rank: 8080
Omega Ratio Rank
ASND Calmar Ratio Rank: 8888
Calmar Ratio Rank
ASND Martin Ratio Rank: 9090
Martin Ratio Rank

VALE
VALE Risk / Return Rank: 8686
Overall Rank
VALE Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
VALE Sortino Ratio Rank: 8686
Sortino Ratio Rank
VALE Omega Ratio Rank: 8686
Omega Ratio Rank
VALE Calmar Ratio Rank: 8585
Calmar Ratio Rank
VALE Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASND vs. VALE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Vale S.A. (VALE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ASNDVALEDifference
Sharpe ratioReturn per unit of total volatility

-0.34

Sortino ratioReturn per unit of downside risk

-0.21

Omega ratioGain probability vs. loss probability

1.25

1.30

-0.05

Calmar ratioReturn relative to maximum drawdown

3.14

2.66

+0.49

Martin ratioReturn relative to average drawdown

9.32

6.77

+2.54

ASND vs. VALE - Sharpe Ratio Comparison

The current ASND Sharpe Ratio is 1.45, which is comparable to the VALE Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of ASND and VALE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ASND vs. VALE - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum VALE drawdown of -92.78%. Use the drawdown chart below to compare losses from any high point for ASND and VALE.


Loading charts...

Drawdown Indicators


ASNDVALEDifference

Max Drawdown

Largest peak-to-trough decline

-61.72%

-92.78%

+31.06%

Max Drawdown (1Y)

Largest decline over 1 year

-17.62%

-21.16%

+3.54%

Max Drawdown (3Y)

Largest decline over 3 years

-29.15%

-41.94%

+12.79%

Max Drawdown (5Y)

Largest decline over 5 years

-60.46%

-49.79%

-10.67%

Max Drawdown (10Y)

Largest decline over 10 years

-61.72%

-57.60%

-4.12%

Current Drawdown

Current decline from peak

-9.07%

-17.79%

+8.72%

Average Drawdown

Average peak-to-trough decline

-18.75%

-36.59%

+17.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.90%

8.28%

-2.38%

Volatility

ASND vs. VALE - Volatility Comparison

The current volatility for Ascendis Pharma A/S (ASND) is 8.24%, while Vale S.A. (VALE) has a volatility of 8.80%. This indicates that ASND experiences smaller price fluctuations and is considered to be less risky than VALE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASNDVALEDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.24%

8.80%

-0.56%

Volatility (6M)

Calculated over the trailing 6-month period

28.53%

25.80%

+2.73%

Volatility (1Y)

Calculated over the trailing 1-year period

38.17%

31.37%

+6.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.86%

35.50%

+13.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.05%

40.52%

+10.53%

Dividends

ASND vs. VALE - Dividend Comparison

ASND has not paid dividends to shareholders, while VALE's dividend yield for the trailing twelve months is around 3.92%.


PositionTTM20252024202320222021202020192018201720162015
ASND
Ascendis Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VALE
Vale S.A.
3.92%7.29%11.41%7.75%8.63%19.70%2.72%2.63%4.16%3.77%1.06%7.48%

Financials

ASND vs. VALE - Financials Comparison

This section allows you to compare key financial metrics between Ascendis Pharma A/S and Vale S.A.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ASND and VALE have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VALE has higher volatility (8.80%) compared to ASND (8.24%). In terms of maximum drawdown, ASND dropped -61.72% vs VALE's -92.78%.

VALE currently has the higher Sharpe Ratio (1.79 vs 1.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASND and VALE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer